Taken collectively, these data provide compelling evidence that the increases in eIF2α phosphorylation through dysregulated eIF2α kinase activities may be closely associated with the pathogenesis or acceleration of AD and responsible for disrupting memory processes in this disease. This evidence concerns the gene EIF2A and Alzheimer disease.